Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02344342 · ClinicalTrials.gov registry record · NA
University of Michigan Advanced Heart Failure Tele-Monitoring and Flexible Diuretic Project
A NA study, sponsored by University of Michigan.
- Terminated
- Registry status
- NA
- Development phase
- 51
- Enrollment target
NCT02344342: Clinical Trial NA study, sponsored by University of Michigan.
NCT02344342 is a NA study that was terminated before completion, run by University of Michigan. The registered enrollment target is 51 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02344342, a NA study, was terminated before completion, sponsored by University of Michigan.
- TERMINATED
- Registry status
- NA
- Development phase
- 51 participants
- Enrollment target
Study Summary
The proposed project is a 2x2 factorial designed study aimed at assessing the impact of 1) a home tele-monitoring system and 2) a flexible diuretic regimen among high risk heart failure patients in the University of Michigan Health System (UMHS).
Primary Outcome
This is the total combined number of days that all participants in each arm were hospitalized or dead between day 1 and day 180. It is a method to combine the endpoints of death and hospitalization used in heart failure trials. Days hospitalized for all participants are added to days dead for all participants, per arm.
Interventions
- DEVICE Telemonitoring
- OTHER Flexible Diuretic Regimen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-12 |
| Phase | NA |
Why NCT02344342 stopped before completion
NCT02344342 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Telemonitoring is the first listed.
NCT02344342 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02344342 about?
NCT02344342 is a clinical study titled "University of Michigan Advanced Heart Failure Tele-Monitoring and Flexible Diuretic Project". The proposed project is a 2x2 factorial designed study aimed at assessing the impact of 1) a home tele-monitoring system and 2) a flexible diuretic regimen among high risk heart failure patients in the University of Michigan Health System (UMHS).
What is the current status of trial NCT02344342?
This trial is currently terminated. It is a NA study. The enrollment target is 51 participants. The study started on 2015-02. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02344342?
The interventions under investigation include: Telemonitoring (DEVICE), Flexible Diuretic Regimen (OTHER).
Who is sponsoring clinical trial NCT02344342?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02344342's enrollment target sits among peer trials
51 1279th of 2000 higher than 722 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia